HFS
ADPT icon

Hughes Financial Services’s Adaptive Biotechnologies ADPT Stock Holding History

Hughes Financial Services’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Hold
51
– – ﹤0.01% 897
2026
Q1 		$708 Sell
51
-7
-12% -$112 ﹤0.01% 853
2025
Q4 		$942 Sell
58
-7
-11% -$114 ﹤0.01% 726
2025
Q3 		$956 Hold
65
– – ﹤0.01% 736
2025
Q2 		$760 Buy
+65
New +$590 ﹤0.01% 780

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hughes Financial Services's ADPT Position: Q2 2026 in Review

Hughes Financial Services held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 51 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #897.

Hughes Financial Services first reported a position in ADPT in Q2 2025 and has held it in 5 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Hughes Financial Services held 51 shares of Adaptive Biotechnologies worth $1.09K as of Q2 2026.
  • Hughes Financial Services left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #897 holding.
  • Hughes Financial Services first reported a position in Adaptive Biotechnologies in Q2 2025 and has held it in 5 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.